HTG Molecular Diagnostics, Inc. Convertible Notes Payable, Noncurrent
HTG Molecular Diagnostics, Inc. had Convertible Notes Payable, Noncurrent of $2.98 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2020-03-25
- 2019-09-30: Convertible Notes Payable, Noncurrent $2.98M.
- 2019-06-30: Convertible Notes Payable, Noncurrent $2.98M.
- 2019-03-31: Convertible Notes Payable, Noncurrent $2.98M.
- 2018-12-31: Convertible Notes Payable, Noncurrent $2.97M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2019-09-30 | $2.98M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.98M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $2.98M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.97M 10-K · filed 2020-03-25 |
| 2018-09-30 | $2.97M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.97M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.96M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.96M 10-K · filed 2019-03-07 |